Dassault Acquires Medidata For $92.25 Per Share In Cash Or $5.8B

Dassault Systemes (DASTY) and Medidata Solutions (MDSO) announced overnight the signing of a definitive agreement for Dassault to acquire Medidata in an all-cash transaction at a price of $ 92.25 per share of Medidata, representing an enterprise value of $5.8B.

Shares of Medidata closed yesterday up $3.96 to $94.75.

The transaction was unanimously approved by the boards of both companies. "With the acquisition of U.S.-based Medidata and its clinical and commercial solutions, Dassault Systemes will reinforce its position as a science-based company by providing the Life Sciences industry with an integrated business experience platform for an end-to-end approach to research and discovery, development, clinical testing, manufacturing and commercialization of new therapies and health technologies," the company said in a statement.

Completion of the acquisition is expected during the last quarter of 2019 and is subject to certain regulatory approvals and approval by the majority of Medidata's shareholders. 

Disclosure: None

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.